cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLCcardiovascular-1028Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEW ARTICLESМесто внутривенных нитратов в современной кардиологииIntravenous nitrates in modern cardiologyЖировИ. В.ZhirovI. V.stereschenko@yandex.ruТерещенкоС. Н.TereshchenkoS. N.stereschenko@yandex.ruГОУ ВПО Московский государственный медико-стоматологический университет, МоскваMoscow State Medico-Stomatological University, Moscow20052012200546, ч.I97101Copyright © Жиров И.В., Терещенко С.Н., 20052005Жиров И.В., Терещенко С.Н.Zhirov I.V., Tereshchenko S.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/1028

Нитраты с успехом применяются в кардиологии, начиная с XIX века. В настоящее время при неотложных состояниях преимуществом пользуются внутривенные формы. Многочисленные исследования доказывают высокую клиническую эффективность и безопасность назначения внутривенных форм нитратов при остром коронарном синдроме, острой сердечной недостаточности, острой декомпенсации хронической сердечной недостаточности.

Nitrates are widely used in cardiology since XIX century. In modern urgent cardiology, intravenous nitrates are administered most often. Numerous studies confirm high clinical efficacy and safety of intravenous nitrates in acute coronary syndromes, acute heart failure, or acute decompensation of chronic heart failure.

острый коронарный синдромнитратыострая сердечная недостаточностьacute coronary syndromesnitratesacute heart failureReferencesMikolich J, Nicoloff N, Robinson P, еt al. Relief of refractory angina with continuous intravenous infusion of nitroglycerin. Chest 1980; 77: 375-8.Mikolich J, Nicoloff N, Robinson P, еt al. Relief of refractory angina with continuous intravenous infusion of nitroglycerin. Chest 1980; 77: 375-8.Leinbach R. Gold H. Intermittent and continuous nitroglycerin infusion for control of myocardial ischemia. Circulation 1977; 56; 194-7.Leinbach R. Gold H. Intermittent and continuous nitroglycerin infusion for control of myocardial ischemia. Circulation 1977; 56; 194-7.Dauwe F, Affaki G, Waters D, et al. Intravenous nitroglycerin in refractory unstable angina. Am J Cardiol 1979; 43: 416-20.Dauwe F, Affaki G, Waters D, et al. Intravenous nitroglycerin in refractory unstable angina. Am J Cardiol 1979; 43: 416-20.Gobel E, Hautvast R, van Gilst W, et al. Randomised, doubleblind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 1995; 346: 1653-7.Gobel E, Hautvast R, van Gilst W, et al. Randomised, doubleblind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 1995; 346: 1653-7.Yusuf S, Wittes J, Friedman L. Overview of results of randomized trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988; 260: 2259-63.Yusuf S, Wittes J, Friedman L. Overview of results of randomized trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988; 260: 2259-63.Figueras J, Lidon R, Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest Eur Heart J 1991; 12: 405-11.Figueras J, Lidon R, Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest Eur Heart J 1991; 12: 405-11.Староверов И.И. Нитраты при остром коронарном синдроме. Кардиология 2005; 10: 82-4.Староверов И.И. Нитраты при остром коронарном синдроме. Кардиология 2005; 10: 82-4.Smith SC, Blair SN, Bonow RO, et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001; 104: 1577-9.Smith SC, Blair SN, Bonow RO, et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001; 104: 1577-9.Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109: 672-93.Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109: 672-93.Gоbel E, van Gilst W, de Kam P, et al. Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris. Eur Heart J 1998; 19: 1208-13.Gоbel E, van Gilst W, de Kam P, et al. Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris. Eur Heart J 1998; 19: 1208-13.Doucet S, Malekianpour M, Theroux P, et al. Randomized Trial Comparing Intravenous Nitroglycerin and Heparin for Treatment of Unstable Angina Secondary to Restenosis After Coronary Artery Angioplasty. Circulation 2000; 101: 955-61.Doucet S, Malekianpour M, Theroux P, et al. Randomized Trial Comparing Intravenous Nitroglycerin and Heparin for Treatment of Unstable Angina Secondary to Restenosis After Coronary Artery Angioplasty. Circulation 2000; 101: 955-61.Curfman GD, Heinsimer JA, Lozner EC, et al. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective, randomized trial. Circulation 1983; 67: 276-82.Curfman GD, Heinsimer JA, Lozner EC, et al. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective, randomized trial. Circulation 1983; 67: 276-82.Yusuf S, Collins R, MacMahon S, et al. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomized trials. Lancet 1988; 1: 1088-92.Yusuf S, Collins R, MacMahon S, et al. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomized trials. Lancet 1988; 1: 1088-92.Hennekens C, Albert C, Godfried S, et al. Adjunctive Drug Therapy of Acute Myocardial Infarction - Evidence from Clinical Trials. N Engl J Med 1996; 335(22): 1660-8.Hennekens C, Albert C, Godfried S, et al. Adjunctive Drug Therapy of Acute Myocardial Infarction - Evidence from Clinical Trials. N Engl J Med 1996; 335(22): 1660-8.ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.Tavazzi L, Volpi АA. Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell’ Infarto Miocardico (GISSI) Trials. Circulation 1997; 95(5): 1341-5.Tavazzi L, Volpi АA. Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell’ Infarto Miocardico (GISSI) Trials. Circulation 1997; 95(5): 1341-5.Jugdutt BI. Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy. Can J Cardiol 1993; 9: 103-14.Jugdutt BI. Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy. Can J Cardiol 1993; 9: 103-14.Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: effect of timing, dosage, and infarct location. Circulation 1988; 78: 906-19.Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: effect of timing, dosage, and infarct location. Circulation 1988; 78: 906-19.Gibbons R, Valeti U, Araoz P, et al. The quantification of infarct size. JACC 2004; 44(8): 1533-42.Gibbons R, Valeti U, Araoz P, et al. The quantification of infarct size. JACC 2004; 44(8): 1533-42.Arend S, Bax J, Hermans J, et al. The short-term effect of intravenous nitroglycerin on haematocrit; an additional benefit in patients with myocardial ischaemia? Eur Heart J 1994; 15: 114-9.Arend S, Bax J, Hermans J, et al. The short-term effect of intravenous nitroglycerin on haematocrit; an additional benefit in patients with myocardial ischaemia? Eur Heart J 1994; 15: 114-9.Lange RA, Hillis LD. Cardiovascular сomplications of cocaine use. N Engl J Med 2001; 345: 351-8.Lange RA, Hillis LD. Cardiovascular сomplications of cocaine use. N Engl J Med 2001; 345: 351-8.Baumann B, Perrone J, Hornig S, et al. Randomized, Double-blind, Placebo-controlled Trial of Diazepam, Nitroglycerin, or Both for Treatment of Patients with Potential Cocaine-associated Acute Coronary Syndromes. Acad Emergency Med 2000; 7: 878-85.Baumann B, Perrone J, Hornig S, et al. Randomized, Double-blind, Placebo-controlled Trial of Diazepam, Nitroglycerin, or Both for Treatment of Patients with Potential Cocaine-associated Acute Coronary Syndromes. Acad Emergency Med 2000; 7: 878-85.Hollander JE. Cocaine-associated acute coronary syndromes. Ann Emergency Med 2001; 38: 95-6.Hollander JE. Cocaine-associated acute coronary syndromes. Ann Emergency Med 2001; 38: 95-6.Лазебник Л.Б., Терещенко С.Н. Нитраты в купировании отека легких у больных с острым инфарктом миокарда. Мед критич сост 2004; 1: 20-2.Лазебник Л.Б., Терещенко С.Н. Нитраты в купировании отека легких у больных с острым инфарктом миокарда. Мед критич сост 2004; 1: 20-2.Гуглина М.Э. Струйное внутривенное введение нитроглицерина при кардиогенном шоке. Клин мед 1990; 8: 56-8.Гуглина М.Э. Струйное внутривенное введение нитроглицерина при кардиогенном шоке. Клин мед 1990; 8: 56-8.Califf R, Bengtson JR. Cardiogenic Shock. N Engl J Med 1994; 330(24):1724-30.Califf R, Bengtson JR. Cardiogenic Shock. N Engl J Med 1994; 330(24):1724-30.Bolognese L, Cerisano G, Buonamici P, et al. Influence of InfarctZone Viability on Left Ventricular Remodeling After Acute Myocardial Infarction. Circulation 1997; 96(10): 3353-9.Bolognese L, Cerisano G, Buonamici P, et al. Influence of InfarctZone Viability on Left Ventricular Remodeling After Acute Myocardial Infarction. Circulation 1997; 96(10): 3353-9.Лазебник Л.Б., Терещенко С.Н., Гендельман А.М. Сравнение клинико-гемодинамических эффектов нитроглицерина, изосорбида динитрата и изосорбид-5-мононитрата при остром инфаркте миокарда. Кардиология 1991; 31: 13-5.Лазебник Л.Б., Терещенко С.Н., Гендельман А.М. Сравнение клинико-гемодинамических эффектов нитроглицерина, изосорбида динитрата и изосорбид-5-мононитрата при остром инфаркте миокарда. Кардиология 1991; 31: 13-5.ACC/AHA Guidelines for the Management of Patients With STElevation Myocardial Infarction—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). JACC 2004; 44: 671-719.ACC/AHA Guidelines for the Management of Patients With STElevation Myocardial Infarction—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). JACC 2004; 44: 671-719.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J doi:10.1093/eurheartj/ehi044.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J doi:10.1093/eurheartj/ehi044.Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of highdose isosorbide dinitrate plus low-dose furosemide versus highdose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-93.Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of highdose isosorbide dinitrate plus low-dose furosemide versus highdose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-93.Терещенко С.Н., Гендельман А.М., Лазебник Л.Б. и др. Купирование отека легких введением 0,1% раствора нитроглицерина болюсом. Сов мед 1991; 12: 57-9.Терещенко С.Н., Гендельман А.М., Лазебник Л.Б. и др. Купирование отека легких введением 0,1% раствора нитроглицерина болюсом. Сов мед 1991; 12: 57-9.Levy P, Hexdall A, Gordon P, et al. A Randomized Trial of Bolus Nitroglycerin for the Treatment of Acute Congestive Heart Failure. Acad Emerg Med 2003; 10(5): 544-5.Levy P, Hexdall A, Gordon P, et al. A Randomized Trial of Bolus Nitroglycerin for the Treatment of Acute Congestive Heart Failure. Acad Emerg Med 2003; 10(5): 544-5.Eryonucu B. Comparison of the Effects of Nitroglycerin and Nitroprusside on Transmitral Doppler Flow Parameters in Patients with Hypertensive Urgency. Ann Pharmacother 2005; 39: 997-1001.Eryonucu B. Comparison of the Effects of Nitroglycerin and Nitroprusside on Transmitral Doppler Flow Parameters in Patients with Hypertensive Urgency. Ann Pharmacother 2005; 39: 997-1001.Varon J, Marik P. The Diagnosis and Management of Hypertensive Crises. Chest 2000; 118: 214-27.Varon J, Marik P. The Diagnosis and Management of Hypertensive Crises. Chest 2000; 118: 214-27.Apostolidou I, Despotis G, Hogue JrC, et al. Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 417-22.Apostolidou I, Despotis G, Hogue JrC, et al. Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 417-22.Perry GY, Murali S, Uretsky BF. Continuous six-month infusion of intravenous nitroglycerin in a patient awaiting cardiac transplantation. Chest 1991; 100: 1470-1.Perry GY, Murali S, Uretsky BF. Continuous six-month infusion of intravenous nitroglycerin in a patient awaiting cardiac transplantation. Chest 1991; 100: 1470-1.Kawashima M, Bando T, Nakamura T, et al. Cytoprotective Effects of Nitroglycerin in Ischemia-Reperfusion-Induced Lung Injury. Am J Respir Crit Care Med 2000; 161: 935-43.Kawashima M, Bando T, Nakamura T, et al. Cytoprotective Effects of Nitroglycerin in Ischemia-Reperfusion-Induced Lung Injury. Am J Respir Crit Care Med 2000; 161: 935-43.Margonato A, Bonetti F, Mailhac A, et al. Intravenous nitroglycerin suppresses exercise-induced arrhythmias in patients with ischaemic heart disease: implications for long-term treatment. Eur Heart J 1991; 12: 1278-82.Margonato A, Bonetti F, Mailhac A, et al. Intravenous nitroglycerin suppresses exercise-induced arrhythmias in patients with ischaemic heart disease: implications for long-term treatment. Eur Heart J 1991; 12: 1278-82.Bode V, Welzel D, Franz G, et al. Absense of drug interaction between heparin and nitroglycerin. Arch Intern Med 1990; 150: 2117-9.Bode V, Welzel D, Franz G, et al. Absense of drug interaction between heparin and nitroglycerin. Arch Intern Med 1990; 150: 2117-9.Gonzalez ER, Jones HD, Graham S, et al. Assessment of the drug interaction between intravenous nitroglycerin and heparin. Ann Pharmacother 1992; 26: 1512-4.Gonzalez ER, Jones HD, Graham S, et al. Assessment of the drug interaction between intravenous nitroglycerin and heparin. Ann Pharmacother 1992; 26: 1512-4.

The authors declare that there are no conflicts of interest present.